Introduction: Chronic obstructive pulmonary disease is a common preventable and treatable respiratory disease which is one of the leading causes of morbidity and mortality world wide. Metabolic syndrome is one of the frequently seen comorbities of COPD. Systemic inflammation is common component of both metabolic syndrome and COPD. Objective: The aim of this study is to assess the prevalence of metabolic syndrome in COPD patients. Methods: This observational study included 70 COPD patients. Metabolic syndrome was defined using criteria of WHO. COPD patients were selected after getting spirometry done; followed by staging according to the Global initiative for obstructive lung disease (GOLD) criteria. Results: Metabolic syndrome was present in 15.7% of COPD patients .The frequencies of metabolic syndrome in patients with GOLD stages I ,II , III, IV were 9.09% , 45.45%, 37.29% and 25.42% respectively. Conclusion: Most of the COPD patients were from urban residence having metabolic syndrome as compared to rural, which is statistically significant (p<0.001)
